CRISPR Therapeutics AG
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $2.75B
Liabilities Breakdown FY2021
Total Liabilities: $352.4M
Asset Breakdown
Total Assets: $2.75B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $923.0M | 33.5% |
| Accounts Receivable | $305.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $137.6M | 5.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $125.0K | 0.0% |
| Other Assets | $1.69B | 61.4% |
Liabilities Breakdown
Total Liabilities: $352.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $14.8M | 4.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $337.6M | 95.8% |